Toxic epidermal necrolysis (Lyell's syndrome) in a patient treated with amoxicillin with clavulanic acid
Open Access
- 20 July 2026
- journal article
- Published by Astrakhan State Medical University in Astrakhan Medical Journal
- Vol. 21 (2) , 201-210
Abstract
Toxic epidermal necrolysis (Lyell's syndrome) is a life-threatening toxic-allergic reaction with a high mortality rate. The relevance of the problem is due to the risk of developing this reaction to frequently prescribed antibacterial drugs in outpatient practice (in particular, inhibitor-protected penicillins), the complexity of diagnosis, as well as the lack of clinical guidelines approved by the Ministry of Health of the Russian Federation. The purpose of this study was to present a clinical case of toxic epidermal necrolysis associated with the use of amoxicillin+clavulanic acid and to draw attention to the issues of diagnosis and safety of antimicrobial therapy for community-acquired infections at the outpatient stage. Materials and methods . A 76-year-old patient with a history of hypertension, diabetes mellitus, and rectal cancer was prospectively observed for toxic epidermal necrolysis caused by amoxicillin+clavulanic acid, and his primary medical records. Research results . On the third day of taking amoxicillin+clavulanic acid for acute right-sided maxillary sinusitis, the patient developed toxic epidermal necrolysis with a high risk of mortality (≥ 90 % according to the SCORTEN scale). After discontinuation of the medication, hospitalization in a specialized department, and pathogenetic and symptomatic pharmacotherapy for the main and concomitant diseases, the patient showed a stable positive trend and complete regression of the skin lesions by the time of discharge from the hospital. Conclusions . The presented case confirms the need for a thorough collection of a pharmacological history and consultation with a clinical pharmacologist when patients present with any skin lesions associated with the use of medications. The approval of clinical guidelines for toxic epidermal necrolysis is a necessary measure for developing modern treatment and diagnostic strategies for managing patients with this adverse reaction, as well as for updating medical and economic standards for providing healthcare.Keywords
This publication has 14 references indexed in Scilit:
- Recent developments in the research of Stevens-Johnson syndrome and toxic epidermal necrolysis: pathogenesis, diagnosis and treatmentEuropean Journal of Medical Research, 2025
- Association of antibiotics with Stevens–Johnson syndrome and toxic epidermal necrolysis: A real-world pharmacovigilance studyInternational Journal of Antimicrobial Agents, 2025
- Adverse Drug Reactions Resulting From the Use of Chiral Medicines Amoxicillin, Amoxicillin-Clavulanic Acid, and Ceftriaxone: A Mixed Prospective-Retrospective Cohort StudyINQUIRY: The Journal of Health Care Organization, Provision, and Financing, 2024
- Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisJAMA Dermatology, 2023
- Exosomal microRNAs from PBMCs stimulated with culprit drugs enhanced keratinocyte cell death in Stevens–Johnson syndrome/toxic epidermal necrolysisJournal of the European Academy of Dermatology and Venereology, 2023
- Clinical features and outcomes in children with Stevens–Johnson syndrome and toxic epidermal necrolysisThe Journal of Dermatology, 2022
- Amoxicillin-associated Stevens-Johnson syndrome or toxic epidermal necrolysis: systematic reviewJournal of Chemotherapy, 2022
- Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) PatientsPatient Preference and Adherence, 2021
- ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control AnalysisClinical Pharmacology & Therapeutics, 2010
- Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in ItalyJournal of Antimicrobial Chemotherapy, 2007